Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
ValiRx plc
VALCurrent price
1.65 GBX
-0.2 GBX (-10.81%)
Last closed
2.03 GBX
Company
www.valirx.com
ISIN
GB00BLH13C52
Sector
Healthcare
Industry
Biotechnology
Exchange
London Exchange
Capitalization
2 718 820 GBX
Yield for 12 month
-73.60 %
1Y
3Y
5Y
10Y
15Y
VAL
ValiRx plc, a biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom. The company develops VAL201, a short peptide that has completed Phase I/II trials for the treatment of prostate cancer; and VAL401, a reformulation of anti-psychotic drug risperidone, which has completed Phase II clinical trial for the treatment of end-stage non-small cell lung cancer. It also develops VAL301, a peptide ingredient that in pre-clinical development for the treatment of endometriosis; BC201, a combination of the peptide ingredient of VAL201/VAL301 with complementary active components for the treatment for patients suffering severe symptoms of Covid-19; and CLX001, a peptide nanoparticle formulation that is in pre-clinical trial for destruction of cancer cells. ValiRx plc was incorporated in 2000 and is based in England, the United Kingdom. Address: Stonebridge House, England, United Kingdom, CM22 7BD
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
455.55 GBXP/E ratio
–Dividend Yield
–Current Year
+961 977 GBX
Last Year
–
Current Quarter
+961 977 GBX
Last Quarter
–
Current Year
-24 655 776 GBX
Last Year
-22 473 674 GBX
Current Quarter
-12 809 028 GBX
Last Quarter
-11 846 747 GBX
Key Figures VAL
1 year
3 years
5 years
10 years
EBITDA
-2 054 167 GBX
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-40.43 %
PEG Ratio
–
Return On Equity TTM
-63.23 %
Wall Street Target Price
455.55 GBX
Revenue TTM
9 620 GBX
Book Value
0.031 GBX
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.02 GBX
Diluted Eps TTM
-0.02 GBX
Most Recent Quarter
IV 2023
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics VAL
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History VAL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:125
Payout Ratio
–
Last Split Date
06.04.2020
Dividend Date
–
Stock Valuation VAL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
266.7222
Price Sales TTM
282.6202
Enterprise Value EBITDA
-5.9991
Price Book MRQ
0.843
Financials VAL
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators VAL
For 52 weeks
1.85 GBX
15.03 GBX
50 Day MA
2.43 GBX
Shares Short Prior Month
–
200 Day MA
3.76 GBX
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart